Skip to main content

Table 1 Demographic characteristics of study subjects of the groups of treatment

From: A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition

CharacteristicRT sequence N = 14TR Sequence N = 14Total N = 28
Age (years)25.43 ± 5.27 (20–41)23.21 ± 3.76 (20–34)24.32 ± 4.80 (20–41)
Weight (kg)70.47 ± 10.66 (53.8–90.2)69.36 ± 10.11 (58.2–95.9)69.91 ± 10.59 (53.8–95.9)
Height (cm)168.79 ± 4.63 (160–179)169.32 ± 6.62 (157.5–183.5)169.05 ± 5.83 (157.5–183.5)
Body Mass Index (kg/m2)24.69 ± 3.19 (19.8–29.7)24.09 ± 2.07 (21.8–28.5)24.39 ± 2.75 (19.8–29.7)
  1. Data are reported as mean ± standard deviation (range)